A Prospective, Randomized, Double-blind Trial to compare an infiltration of liposomal bupivacaine versus bupivacaine for pain control in untreated, symptomatic irreversible pulpitis.

Trial Profile

A Prospective, Randomized, Double-blind Trial to compare an infiltration of liposomal bupivacaine versus bupivacaine for pain control in untreated, symptomatic irreversible pulpitis.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2017

At a glance

  • Drugs Bupivacaine (Primary) ; Bupivacaine (Primary) ; Epinephrine; Lidocaine
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top